IL6RIL6 chimera for the treatment of neurodegenerative diseases
View Patent ↗The invention relates to the use of IL6RIL6 chimera in the treatment and prevention of neurological diseases and disorders.
1. A method for inducing myelination and remyelination of neurons, comprising administering to a patient in need thereof an effective amount of interleukin-6 receptor
interleukin-6 (IL6RIL6) chimera, thereby resulting in the induction of myelination or remyelination of neurons.
2. The method of claim 1 , for inducing myelination and remyelination of neurons, wherein the patient in need is one suffering from traumatic nerve degeneration or a demyelinating disease of the central nervous system (CNS) or peripheral nervous system (PNS).
3. The method of claim 1 , wherein the patient in need is one suffering from multiple sclerosis (MS).
4. A method in accordance with claim 1 , wherein said IL6RIL6 chimera is administered together with a pharmaceutically acceptable carrier.